STOCK TITAN

Oklo (NYSE: OKLO) sets up new $1B at-the-market stock offering plan

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Oklo Inc. entered into a new equity distribution agreement with a syndicate of investment banks to sell, from time to time, up to $1,000,000,000 of Class A common stock through an at-the-market offering program. Sales may be made on the New York Stock Exchange and other permitted venues at market or negotiated prices, with the company paying up to 1.5% in sales commissions.

Oklo simultaneously terminated its prior equity distribution agreement, which had allowed offerings of up to $1,500,000,000. Under that prior program, the company sold 15,774,224 shares of common stock for gross proceeds of approximately $1,499,867,429, and it incurred no termination penalties. Future sales, if any, will occur under the new agreement and related prospectus supplement filed under the existing Form S-3 shelf registration.

Positive

  • None.

Negative

  • None.

Insights

Oklo refreshes its equity ATM program, keeping fundraising flexibility in place.

Oklo has put in place a new at-the-market equity distribution agreement for up to $1,000,000,000 of Class A common stock, replacing a prior $1,500,000,000 program that is now fully utilized. At-the-market programs let issuers sell shares gradually into the trading market.

The filing states the company sold 15,774,224 shares for about $1,499,867,429 under the prior agreement without termination penalties. The new agreement uses the existing Form S-3 shelf, with sales agents earning up to 1.5% in commissions. Actual capital raised under the new program will depend on if, when and how many shares the company directs the agents to sell.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 1.02 Termination of a Material Definitive Agreement Business
A significant contract was terminated, which may affect business operations or revenue.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
New ATM capacity $1,000,000,000 Maximum aggregate gross sales proceeds under new equity distribution agreement
Prior ATM capacity $1,500,000,000 Maximum aggregate offering price under prior equity distribution agreement
Shares sold under prior ATM 15,774,224 shares Total common shares sold before termination of prior agreement
Proceeds from prior ATM $1,499,867,429 Gross proceeds from shares sold under prior equity distribution agreement
Sales agent commission up to 1.5% Maximum commission on gross sales price per share under new agreement
equity distribution agreement financial
"entered into an equity distribution agreement (the “Sales Agreement”) with Goldman Sachs & Co. LLC"
An equity distribution agreement is a formal plan between a company and financial institutions to sell newly issued shares of the company's stock to investors over a period of time. It helps the company raise money gradually, similar to filling a container with water in stages, rather than all at once. For investors, it provides an organized way to buy shares and can influence the stock's supply and price.
at the market offerings financial
"transactions that are deemed to be “at the market offerings” as defined in Rule 415(a)(4)"
At-the-market offerings are a way for a company to raise cash by selling newly issued shares directly into the open market at the current trading price through a broker, rather than in a single large sale. Think of it like topping up a gas tank a little at a time at whatever the pump price is; it gives the company flexibility to raise money when conditions are favorable but can increase the number of shares outstanding and dilute existing investors, and frequent or large sales can put downward pressure on the stock price.
shelf registration statement on Form S-3 regulatory
"shares will be issued pursuant to the Company’s shelf registration statement on Form S-3"
A shelf registration statement on Form S-3 is a pre-approved filing with the Securities and Exchange Commission that lets an eligible public company register securities in advance and sell them later in one or more offerings without repeating the full registration process. Think of it like a pre-approved funding line: it gives management the flexibility to raise capital quickly when market conditions are right, a move that can affect share supply, dilution and investor returns, so investors monitor it as a signal of potential financing activity.
prospectus supplement regulatory
"The Company intends to file a prospectus supplement, dated May 13, 2026, with the SEC"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
false 0001849056 0001849056 2026-05-13 2026-05-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 13, 2026

 

Oklo Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-40583   86-2292473
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

3190 Coronado Dr.
Santa Clara, CA
  95054
(Address of Principal Executive Offices)   (Zip Code)

 

(650) 550-0127

(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share   OKLO   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On May 13, 2026, Oklo Inc. (the “Company”) entered into an equity distribution agreement (the “Sales Agreement”) with Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Barclays Capital Inc., Cantor Fitzgerald & Co., Guggenheim Securities, LLC, Canaccord Genuity LLC and William Blair & Company, L.L.C. under which the Company may offer and sell, from time to time in its sole discretion, shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), with aggregate gross sales proceeds of up to $1,000,000,000 through an “at the market” equity offering program under which Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Barclays Capital Inc., Cantor Fitzgerald & Co., Guggenheim Securities, LLC, Canaccord Genuity LLC and William Blair & Company, L.L.C. will act as the agents (each, a “Sales Agent” and collectively, the “Sales Agents”).

 

Sales, if any, of Common Stock under the Sales Agreement may be made in ordinary brokers’ transactions, to or through a market maker, on or through the New York Stock Exchange or any other market venue where the securities may be traded, in the over-the-counter market, in privately negotiated transactions, in block trades, in transactions that are deemed to be “at the market offerings” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended, or through a combination of any such methods of sale. The Sales Agents may also sell Common Stock by any other method permitted by law.

 

The securities may be sold at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. The Company will designate the maximum amount of Common Stock to be sold through the Sales Agents on a daily basis or otherwise as the Company and the Sales Agents agree and the minimum price per share at which such Common Stock may be sold. Subject to the terms and conditions of the Sales Agreement, the Sales Agents will use their reasonable efforts consistent with their normal sales and trading practices to sell on the Company’s behalf all of the designated shares of Common Stock. The Company may instruct the Sales Agents not to sell any Common Stock if the sales cannot be effected at or above the price designated by the Company in any such instruction. The Company or any of the Sales Agents may suspend the offering of Common Stock by notifying the other party.

 

The Sales Agreement provides that the Company will pay the Sales Agents a commission of up to 1.5% of the gross sales price per share of Common Stock sold through such Sales Agents under the Sales Agreement, and the Company will reimburse the Sales Agents for certain expenses incurred in connection with their services under the Sales Agreement. The offering of Common Stock pursuant to the Sales Agreement will terminate upon the termination of the Sales Agreement by the Company or by the Sales Agents, as provided therein.

 

The Sales Agreement contains representations and warranties and covenants that are customary for transactions of this type. In addition, the Company has agreed to indemnify the Sales Agents against certain liabilities on customary terms, subject to limitations on such arrangements imposed by applicable law and regulation. In the ordinary course of its business, the Sales Agents and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with the Company and its affiliates. The Sales Agents have received, or may in the future receive, customary fees and commissions for these transactions.

 

The shares will be issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-291157) as subsequently amended by that Amendment No. 1 to Form S-3, which was declared effective by the Securities and Exchange Commission (the “SEC”) on December 4, 2025 (the “Shelf Registration Statement”). The Company intends to file a prospectus supplement, dated May 13, 2026, with the SEC in connection with the offer and sale of the shares pursuant to the Sales Agreement.

 

The foregoing description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement. A copy of the Sales Agreement is filed with this Current Report on Form 8-K as Exhibit 1.1 and is incorporated herein by reference.

 

1 

 

 

A copy of the legal opinion of Orrick, Herrington & Sutcliffe LLP, relating to the validity of the shares of Common Stock that may be sold pursuant to the Sales Agreement, is filed with this Current Report on Form 8-K as Exhibit 5.1.

 

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be any offer, solicitation or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

 

Item 1.02. Termination of a Material Definitive Agreement.

 

On May 13, 2026, the Company delivered written notice of its intention to terminate the Equity Distribution Agreement, dated as of December 4, 2025 (the “Prior Sales Agreement”), by and among the Company and each of Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, Barclays Capital Inc., TD Securities (USA) LLC, Guggenheim Securities, LLC, B. Riley Securities, Inc. and William Blair & Company, L.L.C. (collectively, the “Prior Sales Agents”).

 

The termination of the Prior Sales Agreement was effective as of the close of business on May 13, 2026. As previously reported, pursuant to the terms of the Prior Sales Agreement and the related prospectus supplement filed with the SEC on December 4, 2025, the Company could offer and sell shares of its Common Stock having an aggregate offering price of up to $1,500,000,000, from time to time through the Prior Sales Agents. The Company is not subject to any termination penalties related to the termination of the Prior Sales Agreement. The Company sold 15,774,224 shares of its Common Stock for gross proceeds of approximately $1,499,867,429 pursuant to the Prior Sales Agreement through the termination date of such Prior Sales Agreement. The Company will not make any further sales of shares of its Common Stock under the Prior Sales Agreement and the related prospectus supplement.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits. The following exhibits are included in this report:

 

No.  Description
1.1  Equity Distribution Agreement, dated as of May 13, 2026, by and among the Company and Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Barclays Capital Inc., Cantor Fitzgerald & Co., Guggenheim Securities, LLC, Canaccord Genuity LLC and William Blair & Company, L.L.C.
5.1  Opinion of Orrick, Herrington & Sutcliffe LLP.
23.1  Consent of Orrick, Herrington & Sutcliffe LLP (included in Exhibit 5.1).
104  Cover Page Interactive Data File (formatted in iXBRL)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Oklo Inc.
   
Dated: May 13, 2026 /s/ R. Craig Bealmear
  R. Craig Bealmear
  Chief Financial Officer

 

3

FAQ

What equity offering program did Oklo (OKLO) announce in this 8-K?

Oklo entered a new equity distribution agreement allowing sales of up to $1,000,000,000 of Class A common stock through an at-the-market program. Shares may be sold on the NYSE and other venues at prevailing or negotiated prices via multiple sales agents.

Which banks are acting as sales agents in Oklo's new at-the-market program?

The sales agents are Goldman Sachs, BofA Securities, Citigroup, J.P. Morgan, Morgan Stanley, Barclays, Cantor Fitzgerald, Guggenheim Securities, Canaccord Genuity, and William Blair. They will use reasonable efforts to sell designated shares and can earn commissions up to 1.5% of gross sales.

What happened to Oklo's prior equity distribution agreement?

Oklo terminated its prior equity distribution agreement effective May 13, 2026. That earlier program allowed up to $1,500,000,000 of stock sales and is now ended, with no termination penalties owed to the prior sales agents under the agreement.

How much stock did Oklo sell under the prior at-the-market agreement?

Under the prior equity distribution agreement, Oklo sold 15,774,224 shares of its common stock for gross proceeds of approximately $1,499,867,429. Following termination, the company will make no further sales under that prior agreement or its related prospectus supplement.

Under what registration does Oklo's new at-the-market offering operate?

The new at-the-market offering will use Oklo’s shelf registration statement on Form S-3 (File No. 333-291157), as amended and declared effective on December 4, 2025. Oklo plans to file a May 13, 2026 prospectus supplement describing sales under the new equity distribution agreement.

What commissions and protections are included for Oklo's sales agents?

Sales agents may receive a commission of up to 1.5% of the gross sales price per share plus certain reimbursed expenses. Oklo also agreed to customary representations, covenants, and indemnification provisions in favor of the sales agents, subject to applicable legal and regulatory limits.

Filing Exhibits & Attachments

5 documents